Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30219% above fair value
$46.85+1.40 (+3.08%)
Close on Nov 18, 2026Market cap $7.86BP/E 123.3Yield –
Alkermes shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Alkermes's shares outstanding was 173M at Jun 30, 2026. For fiscal 2025 it was 169M, down 0.3% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is 170M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 169M | -0.3% |
| FY2024 | Dec 31, 2024 | 169M | -0.3% |
| FY2023 | Dec 31, 2023 | 170M | +3.7% |
| FY2022 | Dec 31, 2022 | 164M | -0.6% |
| FY2021 | Dec 31, 2021 | 165M | +3.7% |
| FY2020 | Dec 31, 2020 | 159M | +1.1% |
| FY2019 | Dec 31, 2019 | 157M | +1.3% |
| FY2018 | Dec 31, 2018 | 155M | +1.1% |
| FY2017 | Dec 31, 2017 | 153M | +1.3% |
| FY2016 | Dec 31, 2016 | 151M | +1.5% |
| FY2015 | Dec 31, 2015 | 149M | +8.8% |
| FY2013 | Mar 31, 2013 | 137M | +19.5% |
| FY2012 | Mar 31, 2012 | 115M | +20.0% |
| FY2011 | Mar 31, 2011 | 96M | +0.8% |
| FY2010 | Mar 31, 2010 | 95M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 173M | +3.0% |
| Q1 FY2026 | Mar 31, 2026 | 166M | -1.5% |
| Q4 FY2025 | Dec 31, 2025 | 170M | +2.1% |
| Q3 FY2025 | Sep 30, 2025 | 169M | +0.9% |
| Q2 FY2025 | Jun 30, 2025 | 168M | -1.5% |
| Q1 FY2025 | Mar 31, 2025 | 169M | -2.5% |
| Q4 FY2024 | Dec 31, 2024 | 166M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | 167M | -2.8% |
| Q2 FY2024 | Jun 30, 2024 | 171M | -0.3% |
| Q1 FY2024 | Mar 31, 2024 | 173M | +4.8% |
| Q4 FY2023 | Dec 31, 2023 | 166M | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | 172M | +4.6% |
| Q2 FY2023 | Jun 30, 2023 | 172M | +4.7% |
| Q1 FY2023 | Mar 31, 2023 | 165M | +1.6% |
| Q4 FY2022 | Dec 31, 2022 | 164M | -7.2% |
| Q3 FY2022 | Sep 30, 2022 | 164M | +1.8% |
| Q2 FY2022 | Jun 30, 2022 | 164M | -0.1% |
| Q1 FY2022 | Mar 31, 2022 | 162M | +1.8% |
| Q4 FY2021 | Dec 31, 2021 | 177M | +11.3% |
| Q3 FY2021 | Sep 30, 2021 | 161M | +1.5% |
| Q2 FY2021 | Jun 30, 2021 | 164M | +3.2% |
| Q1 FY2021 | Mar 31, 2021 | 160M | +1.0% |
| Q4 FY2020 | Dec 31, 2020 | 159M | +0.9% |
| Q3 FY2020 | Sep 30, 2020 | 159M | +1.2% |
| Q2 FY2020 | Jun 30, 2020 | 159M | +1.2% |
| Q1 FY2020 | Mar 31, 2020 | 158M | +1.1% |
| Q4 FY2019 | Dec 31, 2019 | 158M | +1.4% |
| Q3 FY2019 | Sep 30, 2019 | 157M | +1.2% |
| Q2 FY2019 | Jun 30, 2019 | 157M | +1.2% |
| Q1 FY2019 | Mar 31, 2019 | 156M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | 156M | +1.1% |
| Q3 FY2018 | Sep 30, 2018 | 155M | +1.1% |
| Q2 FY2018 | Jun 30, 2018 | 155M | +1.2% |
| Q1 FY2018 | Mar 31, 2018 | 154M | +1.1% |
| Q4 FY2017 | Dec 31, 2017 | 154M | +1.1% |
| Q3 FY2017 | Sep 30, 2017 | 154M | +1.3% |
| Q2 FY2017 | Jun 30, 2017 | 153M | – |
| Q1 FY2017 | Mar 31, 2017 | 153M | – |
| Q4 FY2016 | Dec 31, 2016 | 152M | – |
| Q3 FY2016 | Sep 30, 2016 | 152M | – |
See a number that looks wrong?